CWAG
ABBV icon

Compton Wealth Advisory Group’s AbbVie ABBV Stock Holding History

Compton Wealth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.25M Buy
15,095
+3,256
+28% +$722K 0.72% 30
2025
Q4 		$2.71M Buy
11,839
+70
+0.6% +$15.9K 0.59% 33
2025
Q3 		$2.73M Buy
11,769
+202
+2% +$41.1K 0.63% 33
2025
Q2 		$2.15M Buy
11,567
+119
+1% +$22.1K 0.54% 35
2025
Q1 		$2.4M Buy
11,448
+42
+0.4% +$8.16K 0.67% 31
2024
Q4 		$2.03M Sell
11,406
-221
-2% -$40.6K 0.52% 40
2024
Q3 		$2.3M Sell
11,627
-83
-0.7% -$15.5K 0.58% 37
2024
Q2 		$2.01M Buy
11,710
+452
+4% +$74.9K 0.54% 40
2024
Q1 		$2.05M Buy
11,258
+102
+0.9% +$17.6K 0.56% 40
2023
Q4 		$1.73M Buy
11,156
+1,155
+12% +$168K 0.54% 40
2023
Q3 		$1.49M Buy
10,001
+65
+0.7% +$9.54K 0.51% 37
2023
Q2 		$1.34M Sell
9,936
-179
-2% -$26.2K 0.45% 41
2023
Q1 		$1.61M Buy
10,115
+5,982
+145% +$915K 0.56% 38
2022
Q4 		$668K Buy
4,133
+100
+2% +$15.3K 0.26% 61
2022
Q3 		$541K Sell
4,033
-84
-2% -$12.1K 0.23% 64
2022
Q2 		$630K Buy
4,117
+260
+7% +$39.7K 0.27% 65
2022
Q1 		$625K Buy
3,857
+1,255
+48% +$182K 0.24% 71
2021
Q4 		$352K Sell
2,602
-172
-6% -$20.3K 0.15% 68
2021
Q3 		$299K Buy
2,774
+18
+0.7% +$2.06K 0.14% 67
2021
Q2 		$310K Buy
2,756
+18
+0.7% +$2.03K 0.14% 66
2021
Q1 		$296K Buy
2,738
+27
+1% +$2.89K 0.17% 68
2020
Q4 		$290K Sell
2,711
-357
-12% -$34.3K 0.18% 64
2020
Q3 		$269K Buy
3,068
+409
+15% +$38.5K 0.2% 60
2020
Q2 		$261K Buy
2,659
+27
+1% +$2.38K 0.28% 58
2020
Q1 		$200K Buy
2,632
+200
+8% +$17K 0.26% 52
2019
Q4 		$215K Sell
2,432
-10,740
-82% -$892K 0.19% 54
2019
Q3 		$997K Sell
13,172
-786
-6% -$53.9K 0.55% 37
2019
Q2 		$1.01M Hold
13,958
– – 0.52% 34
2019
Q1 		$1.13M Hold
13,958
– – 0.6% 32
2018
Q4 		$1.29M Buy
+13,958
New +$1.23M 0.66% 23

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Compton Wealth Advisory Group's ABBV Position: Q1 2026 in Review

Compton Wealth Advisory Group increased its AbbVie (ABBV) stake by 28% in Q1 2026, buying an estimated $722K and bringing the position to 15,095 shares worth $3.25M. The position accounts for 0.72% of the portfolio, ranked #30.

Compton Wealth Advisory Group first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Compton Wealth Advisory Group held 15,095 shares of AbbVie worth $3.25M as of Q1 2026.
  • Compton Wealth Advisory Group bought 3,256 AbbVie shares in Q1 2026, an estimated $722K.
  • AbbVie made up 0.72% of Compton Wealth Advisory Group's portfolio in Q1 2026, its #30 holding.
  • Compton Wealth Advisory Group first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Compton Wealth Advisory Group's 13F filing for Q1 2026, filed 14 Apr 2026.